Get the Stockscreener App
0.2353
2.30%
0.0053
After Hours:
.23
-0.0053
-2.25%
Mustang Bio Inc stock is traded at $0.2353, with a volume of 240.49K.
It is up +2.30% in the last 24 hours and down -16.32% over the past month.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See More
Previous Close:
$0.23
Open:
$0.2299
24h Volume:
240.49K
Relative Volume:
0.11
Market Cap:
$8.76M
Revenue:
-
Net Income/Loss:
$-40.10M
P/E Ratio:
-0.0249
EPS:
-9.46
Net Cash Flow:
$-36.99M
1W Performance:
+10.31%
1M Performance:
-16.32%
6M Performance:
-77.38%
1Y Performance:
-88.63%
1-Day Range:
$0.2253
$0.2457
1-Week Range:
$0.211
$0.2599
52-Week Range:
$0.1281
$2.13
Mustang Bio Inc Stock (MBIO) Company Profile
Name
Mustang Bio Inc
Sector
Industry
Phone
(781) 652-4500
Address
377 PLANTATION STREET, WORCESTER, NY
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Oct-02-20 | Initiated | B. Riley FBR | Buy |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-19 | Initiated | H.C. Wainwright | Buy |
| Jun-21-19 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-21-17 | Initiated | Oppenheimer | Outperform |
View All
Mustang Bio Inc Stock (MBIO) Latest News
A stock that deserves closer examination: Mustang Bio Inc (MBIO) - US Post News
Mustang Bio Inc (MBIO) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
There is no doubt that Mustang Bio Inc (MBIO) ticks all the boxes. - SETE News
Marshall Wace LLP Has $92.82 Million Position in StoneCo Ltd. (NASDAQ:STNE) - MarketBeat
Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug - Yahoo Finance
Market Update: Mustang Bio Inc (MBIO) Sees Negative Movement, Closing at 0.21 - The Dwinnex
Mustang Bio (MBIO) Stock Price, News & Analysis - MarketBeat
Wild mustangs available for adoption in Cullman County - WVTM13 Birmingham
MBIO’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle
Daily Market Movement: Mustang Bio Inc (MBIO) Sees a -12.17 Decrease, Closing at 0.22 - The Dwinnex
Review: The striking, confident 2025 Ford Mustang, reimagined for the modern era - MarketWatch
DEADLINE ALERT for OM, SAGE, and SMCI: The Law Offices of - GlobeNewswire
Drugmaker for rare disease soars 1,200% in last year - Kursiv Media
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Worcester biopharma faces delisting from Nasdaq - Worcester Business Journal
Bokf Na Purchases 2,755 Shares of USANA Health Sciences, Inc. (NYSE:USNA) - Defense World
As Interest in EVs Ebbs, Ford Reveals its Fastest, Most Powerful Mustang Ever- the 2025 Mustang GTD - Torque News
Ford To Roll Out Limited Edition Street Legal Race Car Variant Of Mustang As Early As This Year - MSN
The 2025 Mustang GTD Is Here, And It's The Most Powerful In History - MSN
Mustang GTD Packs More Powerful Punch Than Any Other Production Pony - Ford Muscle
Mustang Bio faces Nasdaq delisting over equity shortfall - Investing.com India
Mustang Bio Inc’s Market Journey: Closing Weak at 0.27, Down -5.15 - The Dwinnex
Mustang Bio Inc Inc. (MBIO) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
How should investors view Mustang Bio Inc (MBIO)? - US Post News
CAR T Cell Therapy Market Projected To Witness Substantial Growth, 2024-2031: Legend Biotech, Pfizer Inc., - EIN News
Closing Figures: Mustang Bio Inc (MBIO)’s Negative Finish at 0.28, Down -7.07 - The Dwinnex
Mustang Bio Inc (MBIO) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Examining Mustang Bio Inc (MBIO) more closely is necessary - US Post News
In the Green: Mustang Bio Inc (MBIO) Closes at 0.35, Up/Down -7.70 from Previous Day - The Dwinnex
Mustang Bio Inc (MBIO) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Mustang Bio Inc (MBIO) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Mustang Bio Inc (MBIO) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Investors in cash trouble should check out Mustang Bio Inc (MBIO) - SETE News
Market Watch Highlights: Mustang Bio Inc (MBIO) Ends on an Downturn Note at 0.38 - The Dwinnex
Is Mustang Bio Inc (MBIO) a good investment opportunity? - US Post News
MBIO (Mustang Bio) Cash From Discontinued Investing Activit - GuruFocus.com
MBIO (Mustang Bio) Financial Strength : 4 (As of Mar. 2024) - GuruFocus.com
MBIO (Mustang Bio) 9-Day RSI : 46.77 (As of Aug. 15, 2024) - GuruFocus.com
MBIO Stock Earnings: Mustang Bio Beats EPS for Q2 2024 - InvestorPlace
MBIO Stock Earnings: Mustang Bio Beats EPS for Q2 2024 - MSN
Was anything negative for Mustang Bio Inc (MBIO) stock last session? - US Post News
Mustang Bio Inc (MBIO) Stock: Navigating a Year of Volatility - The InvestChronicle
Mustang Bio Inc (MBIO) presents a great opportunity, but the stock is slightly undervalued - US Post News
Mustang Bio Inc (MBIO) Stock: A Year of Decreases and Increases - The InvestChronicle
Market Recap Check: Mustang Bio Inc (MBIO)’s Negative Finish at 0.31, Up/Down -5.36 - The Dwinnex
The growth track for Mustang Bio Inc (MBIO) has changed recently - SETE News
Financial Analysis: Mustang Bio Inc (MBIO)’s Ratios Unveil Key Insights - The Dwinnex
MBIO underperforms with a -3.80 decrease in share price - US Post News
The Significance of Moving Averages in Mustang Bio Inc Inc. (MBIO) Price Performance - The InvestChronicle
A significant driver of top-line growth: Mustang Bio Inc (MBIO) - SETE News
Metric Analysis: Mustang Bio Inc (MBIO)’s Key Ratios in the Limelight - The Dwinnex
Mustang Bio Inc Stock (MBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):